Active Ingredient History
Dihydroartemisinin is a drug used to treat malaria. Dihydroartemisinin is the active metabolite of all artemisinin compounds and is also available as a drug in itself. It is a semi-synthetic derivative of artemisinin and is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs. It is sold commercially in combination with piperaquine and has been shown to be equivalent to artemether/lumefantrine. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia (Phase 4)
Anemia, Sickle Cell (Phase 2/Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cardiotoxicity (Phase 2)
Drug Combinations (Phase 1)
Drug Interactions (Phase 4)
Drugs, Investigational (Phase 2/Phase 3)
Elephantiasis, Filarial (Phase 3)
Fever (Phase 3)
Healthy Volunteers (Phase 4)
Helminthiasis (Phase 3)
HIV (Phase 3)
HIV Infections (Phase 4)
Hookworm Infections (Phase 3)
Lupus Erythematosus, Systemic (Phase 2)
Malaria (Phase 4)
Malaria, Falciparum (Phase 4)
Malaria Vaccines (Phase 2)
Malaria, Vivax (Phase 4)
Neoplasm Metastasis (Phase 3)
Parasitemia (Phase 2)
Pharmacokinetics (Phase 1)
Plasmodium falciparum (Phase 4)
Plasmodium vivax (Phase 1/Phase 2)
Pregnancy (Phase 4)
Pregnancy Complications (Phase 4)
Scabies (Phase 3)
Stomach Neoplasms (Phase 3)
Strongyloidiasis (Phase 3)
Therapeutics (Phase 3)
Treatment Adherence and Compliance (Phase 4)
Trichomonas Vaginitis (Phase 3)
Tropical Medicine (Phase 3)
Vaginosis, Bacterial (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue